LB Pharmaceuticals Inc

LBRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024
Assets
Cash & Equivalents $250.2M $23.0M
Accounts Receivable — —
Inventory — —
Total Current Assets $308.4M $28.9M
Property, Plant & Equipment $1.6M $1.9M
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $312.9M $33.5M
Liabilities
Accounts Payable $2.1M $2.3M
Total Current Liabilities $7.4M $8.1M
Long-Term Debt — —
Total Liabilities $11.6M $13.8M
Stockholders' Equity
Retained Earnings $-129.5M $-104.3M
Total Stockholders' Equity $301.3M $-94.6M